Literature DB >> 29472832

Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.

Katie S Murray1, Oguz Akin2, Jonathan A Coleman3.   

Abstract

Salvage treatment options after localized primary treatment failure of prostate cancer are limited and associated with risk for serious complications. We report on the management details of a 57-year-old African American man treated with partial-gland ablation using irreversible electroporation following local recurrence after brachytherapy and prior salvage cryoablation. Therapeutic and functional outcomes were assessed by conventional means, including serum prostate-specific antigen values and prostate biopsy results.

Entities:  

Keywords:  Focal therapy; Irreversible electroporation; Prostate cancer; Salvage therapy

Year:  2017        PMID： 29472832      PMCID： PMC5811886          DOI： 10.3909/riu0755

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


  21 in total

1.  TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.

Authors:  Abdel-Rahmène Azzouzi; Eric Barret; Caroline M Moore; Arnaud Villers; Clare Allen; Avigdor Scherz; Gordon Muir; Michel de Wildt; Neil J Barber; Souhil Lebdai; Mark Emberton
Journal:  BJU Int       Date:  2013-10       Impact factor: 5.588

2.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

Review 3.  Cell injury by electric forces.

Authors:  Raphael C Lee
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

4.  In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.

Authors:  Robert E Neal; Jeremy L Millar; Helen Kavnoudias; Peter Royce; Franklin Rosenfeldt; Alan Pham; Ryan Smith; Rafael V Davalos; Kenneth R Thomson
Journal:  Prostate       Date:  2014-01-17       Impact factor: 4.104

5.  Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.

Authors:  Ajita Deodhar; Sébastien Monette; Gordon W Single; William C Hamilton; Raymond Thornton; Majid Maybody; Jonathan A Coleman; Stephen B Solomon
Journal:  Urology       Date:  2010-12-15       Impact factor: 2.649

6.  Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Authors:  Sean P Elliott; Maxwell V Meng; Eric P Elkin; Jack W McAninch; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2007-06-13       Impact factor: 7.450

7.  Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.

Authors:  Govindarajan Srimathveeravalli; Mikhail Silk; Thomas Wimmer; Sebastien Monette; Simon Kimm; Majid Maybody; Stephen B Solomon; Jonathan Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2015-03-11       Impact factor: 3.464

8.  Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study.

Authors:  Salvatore Paiella; Giovanni Butturini; Isabella Frigerio; Roberto Salvia; Giulia Armatura; Matilde Bacchion; Martina Fontana; Mirko D'Onofrio; Enrico Martone; Claudio Bassi
Journal:  Dig Surg       Date:  2015-02-28       Impact factor: 2.588

Review 9.  SIU/ICUD Consultation on Urethral Strictures: Posterior urethral stenosis after treatment of prostate cancer.

Authors:  Sender Herschorn; Sean Elliott; Michael Coburn; Hunter Wessells; Leonard Zinman
Journal:  Urology       Date:  2013-12-20       Impact factor: 2.649

10.  Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.

Authors:  W van den Bos; R R Jurhill; D M de Bruin; C D Savci-Heijink; A W Postema; P G K Wagstaff; B G Muller; I M Varkarakis; A Skolarikos; P J Zondervan; M P Laguna Pes; T M de Reijke; J J M C H de la Rosette
Journal:  J Urol       Date:  2016-03-19       Impact factor: 7.450
View more
  1 in total

Review 1.  Focal therapy for primary and salvage prostate cancer treatment: a narrative review.

Authors:  Andrew T Tracey; Lucas M Nogueira; Ricardo G Alvim; Jonathan A Coleman; Katie S Murray
Journal:  Transl Androl Urol       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.